LEXX · Lexaria Bioscience Corp.
$5.34
-0.33 (-5.82%)
At close · Aug 6
View the 10-Q filed Jul 13, 2026
Going-concern doubt
— flagged Jul 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The recurring losses and negative net cash flows raise substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed Jul 13, 2026
Customer concentration
— top customer 100% of revenue
One customer — 100% of revenue (nine months ended May 31, 2026)
“In the nine months ended May 31, 2026, the Company recognized revenue of $20,000 on a consolidated basis. One customer accounted for 100% of that total.”
2 customers — 100% of revenue (nine months ended May 31, 2025)
“In the nine months ended May 31, 2025, the Company recognized revenue of $531,923 on a consolidated basis. Two customers accounted for 100% of that total.”
Market Cap
$132.36M
Shares
24.79M
No listed options were found for LEXX.